Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
9.10
-0.14 (-1.52%)
Oct 20, 2025, 11:10 AM EDT - Market open
Xeris Biopharma Holdings Market Cap
Xeris Biopharma Holdings has a market cap or net worth of $1.47 billion as of October 20, 2025. Its market cap has increased by 238.91% in one year.
Market Cap
1.47B
Enterprise Value
1.69B
1-Year Change
238.91%
Ranking
Category
Stock Price
$9.10
Market Cap Chart
Since October 6, 2021, Xeris Biopharma Holdings's market cap has increased from $295.78M to $1.47B, an increase of 396.82%. That is a compound annual growth rate of 48.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 1.49B | 195.24% |
| Dec 31, 2024 | 505.39M | 55.70% |
| Dec 29, 2023 | 324.59M | 79.47% |
| Dec 30, 2022 | 180.86M | -50.50% |
| Dec 31, 2021 | 365.40M | 23.54% |
| Oct 6, 2021 | 295.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.73B |
| Johnson & Johnson | 465.34B |
| AbbVie | 405.55B |
| UnitedHealth Group | 322.96B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.64B |
| Novo Nordisk | 237.72B |
| Abbott Laboratories | 223.72B |